AMG 691 clinical trials

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

This study is testing a new medicine, AMG 691, for safety in healthy people and those with mild-to-moderate asthma. Researchers want to see how the body reacts to single and multiple doses and check for side effects.